News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are
Dr. Tom Stackhouse, Director of the National Cancer Institute (NCI)’s Technology Transfer Office, will be giving a webinar on Cooperative R&D Agreements, otherwise known as CRADAs. This free event, put on by The Center for Advancing Innovation is a great opportunity for anyone looking to advance an
If you are interested in collaborating on an oncology-related technology, don’t miss the National Cancer Institute’s (NCI) Michael Salgaller and the Office of Technology Transfer’s (OTT) Steven Ferguson’s presentation at the MedInvest Oncology Investor Conference from December 14-15, 2022. This
Are you interested in licensing or collaborating on a new immunotherapy method to target solid tumors? The National Cancer Institute’s distinguished inventor, Dr. John Schiller, will be discussing this invention and fielding questions on December 14, 2022. This technology involves the injection of